Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy and Safety of NNC 0078-0000-0007 in Treatment of Acute Bleeding Episodes in Patients With Congenital Haemophilia and Inhibitors

NCT01392547 is registered in ClinicalTrials.gov with Novo Nordisk A/S as lead sponsor.

NCT NCT01392547
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01392547 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy and Safety of NNC 0078-0000-0007 in Treatment of Acute Bleeding Episodes in Patients With Congenital Haemophilia and Inhibitors
Lead sponsor
Novo Nordisk A/S
Phase
Phase 3
Overall status
Completed
Start date
July 31, 2011
Completion date
August 31, 2012
Enrollment
72 (actual)
Sites
32

Conditions

As the registry lists them; a condition with its own page is linked.

congenital bleeding disorder, haemophilia a with inhibitors, haemophilia b with inhibitors